In Caucasians, polymorphisms in the SAA1 and SAA2 (serum amyloid A1 and A2) genes have been implicated in the pathogenesis of AA amyloidosis in individuals with FFM (34). This evidence concerns the gene SAA1 and AA amyloidosis.